# SILDENAFIL CITRATE
> **ANDA214773** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2022-12-23
## Drug
- **FDA Application Number:** ANDA214773
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILDENAFIL CITRATE
- **Generic name:** SILDENAFIL CITRATE
- **Active ingredients:** SILDENAFIL CITRATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2022-12-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214773)
---
*AI Analytics · CC0 1.0*